Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Notice and Proxy Statement with Respect to the Company's Annual General Meeting of Shareholders
- 99.2 Proxycard for Holders of Ordinary Shares with Respect to the Company's Annual General Meeting of Shareholders
- 99.3 Votinginstruction Card for American Depositary Share Holders with Respect to the Company's Annual General Meeting of Shareholders
CANF similar filings
- 29 Nov 19 Can-Fite Reports Third Quarter 2019 Financial Results & Provides Clinical Update
- 19 Nov 19 Can-Fite Granted Patents for its Sexual Dysfunction Drug
- 12 Nov 19 Report of Foreign Private Issuer
- 6 Nov 19 2019 Annual General Meeting of Shareholders
- 4 Nov 19 Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients
- 31 Oct 19 Successful conclusion of an End of Phase II meeting with the FDA
- 17 Oct 19 Report of Foreign Private Issuer
Filing view
External links
